Janney Capital Management LLC Sells 8,942 Shares of CVS Health Corp (CVS)

Janney Capital Management LLC lessened its holdings in shares of CVS Health Corp (NYSE:CVS) by 4.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 211,429 shares of the pharmacy operator’s stock after selling 8,942 shares during the quarter. Janney Capital Management LLC’s holdings in CVS Health were worth $17,193,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CVS. Horan Capital Advisors LLC. grew its stake in shares of CVS Health by 3.2% in the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after acquiring an additional 1,000 shares during the last quarter. Community Bank N.A. boosted its stake in shares of CVS Health by 7.3% in the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after purchasing an additional 1,362 shares in the last quarter. FIL Ltd boosted its stake in shares of CVS Health by 13.8% in the 2nd quarter. FIL Ltd now owns 514,836 shares of the pharmacy operator’s stock valued at $41,424,000 after purchasing an additional 62,318 shares in the last quarter. Midwest Investment Management LLC boosted its stake in shares of CVS Health by 6.2% in the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after purchasing an additional 1,245 shares in the last quarter. Finally, ETRADE Capital Management LLC boosted its stake in shares of CVS Health by 3.7% in the 2nd quarter. ETRADE Capital Management LLC now owns 55,653 shares of the pharmacy operator’s stock valued at $4,478,000 after purchasing an additional 1,979 shares in the last quarter. 81.69% of the stock is currently owned by institutional investors.

Several equities research analysts have recently commented on CVS shares. Jefferies Group set a $86.00 target price on shares of CVS Health and gave the company a “hold” rating in a research note on Wednesday, October 18th. Mizuho set a $90.00 target price on shares of CVS Health and gave the company a “buy” rating in a research note on Tuesday, October 24th. Robert W. Baird restated a “hold” rating and issued a $77.00 target price on shares of CVS Health in a research note on Friday, October 27th. Loop Capital restated a “hold” rating on shares of CVS Health in a research note on Friday, October 27th. Finally, Cowen set a $86.00 target price on shares of CVS Health and gave the company a “buy” rating in a research note on Sunday, October 29th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $87.77.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.61% of the company’s stock.

CVS Health Corp (NYSE CVS) opened at $69.39 on Friday. The company has a quick ratio of 0.55, a current ratio of 1.02 and a debt-to-equity ratio of 0.59. CVS Health Corp has a twelve month low of $66.45 and a twelve month high of $84.00. The stock has a market capitalization of $71,466.59, a PE ratio of 10.72, a P/E/G ratio of 1.18 and a beta of 0.93.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.88 by $0.04. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business had revenue of $48.39 billion during the quarter, compared to analysts’ expectations of $47.54 billion. During the same period in the previous year, the business posted $1.71 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. research analysts predict that CVS Health Corp will post 6.49 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.88%. CVS Health’s dividend payout ratio is currently 30.91%.

COPYRIGHT VIOLATION NOTICE: This report was posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://www.com-unik.info/2018/02/10/janney-capital-management-llc-sells-8942-shares-of-cvs-health-corp-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit